Log in

SDHA: a key player in T cell-mediated intestinal disease severity

  • Research Highlight
  • Published:
Cellular & Molecular Immunology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1: SDHA downregulation exacerbates the severity of T cell-mediated immunopathology associated with graft-versus-host disease.

References

  1. Voss K, Hong HS, Bader JE, Sugiura A, Lyssiotis CA, Rathmell JC. Nat Rev Immunol. 2021;21:637–52.

    Article  CAS  Google Scholar 

  2. Martínez-Reyes I, Chandel NS. Nat Commun. 2020;11:102.

    Article  Google Scholar 

  3. Urbauer E, Rath E, Haller D. Front Cell Dev Biol 2021;8:602814.

    Article  Google Scholar 

  4. Fujiwara H, Seike K, Brooks MD, Mathew AV, Kovalenko I, Pal A, et al. Nat Immunol. 2021;22:1440–51.

    Article  CAS  Google Scholar 

  5. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, et al. Cancer Cell. 2005;7:77–85.

    Article  CAS  Google Scholar 

  6. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Péquignot E, et al. Nat Genet. 1995;11:144–9.

    Article  CAS  Google Scholar 

  7. Parfait B, Chretien D, Rötig A, Marsac C, Munnich A, Rustin P. Hum Genet. 2000;106:236–43.

    Article  CAS  Google Scholar 

  8. Agirman G, Yu KB, Hsiao EY. Science 2021;374:1087–92.

Download references

Acknowledgements

Research in the author’s laboratory is supported by the Ministry of Science and Innovation and the Spanish Research Agency through FEDER funds (RTI2018-098517-B100) (MICINN/AEI/FEDER, EU). CBMSO receives an institutional grant from the Fundación Ramón Areces and Banco Santander, Spain.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José M. Izquierdo.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Izquierdo, J.M. SDHA: a key player in T cell-mediated intestinal disease severity. Cell Mol Immunol 19, 139–141 (2022). https://doi.org/10.1038/s41423-021-00820-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41423-021-00820-7

  • Springer Nature Limited

Navigation